Trial intelligence / Profile preview

Triptorelin for Ovarian Function Preservation in Breast Cancer

NCT00090844Phase 2Terminated

Sponsor
University of South Florida
Start
Jul 2004
Primary completion
May 2008
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of triptorelin in primary ovarian insufficiency (POI), sponsored by University of South Florida. Started Jul 2004; status: terminated.

02

Drugs

triptorelin
03

Conditions

primary ovarian insufficiency (POI)

Beyond the preview

Go deeper on NCT00090844.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00090844.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call